Nanjing Vazyme Biotech Co Ltd (688105) — Free Cash Flow Generation Index
Nanjing Vazyme Biotech Co Ltd (688105) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥59.46 Million represents 1% of operating cash flow (CN¥75.30 Million). Explore how much does Nanjing Vazyme Biotech Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Nanjing Vazyme Biotech Co Ltd Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Nanjing Vazyme Biotech Co Ltd.
Annual Free Cash Flow Generation for Nanjing Vazyme Biotech Co Ltd (2019–2025)
Year-by-year Free Cash Flow Generation Index for Nanjing Vazyme Biotech Co Ltd. Check Nanjing Vazyme Biotech Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | CN¥185.77 Million | CN¥233.16 Million | CN¥47.39 Million | ▲ +297.8% |
| 2023 | -0.40x | CN¥-79.91 Million | CN¥198.40 Million | CN¥232.90 Million | ▼ -30.0% |
| 2022 | -0.31x | CN¥-227.69 Million | CN¥735.17 Million | CN¥962.86 Million | ▼ -153.8% |
| 2021 | 0.58x | CN¥354.84 Million | CN¥616.80 Million | CN¥261.96 Million | ▼ -29.0% |
| 2020 | 0.81x | CN¥651.01 Million | CN¥803.55 Million | CN¥152.54 Million | ▲ +363.2% |
| 2019 | -0.31x | CN¥-4.68 Million | CN¥15.20 Million | CN¥19.88 Million | — |